Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Operations

v3.7.0.1
Consolidated Statement of Operations - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues:    
Revenues and management fees from company clinics $ 8,578,048 $ 3,651,273
Royalty fees 5,973,079 4,515,203
Franchise fees 2,286,809 2,471,259
Advertising fund revenue 1,866,406 1,191,124
IT related income and software fees 932,709 808,070
Regional developer fees 617,573 866,802
Other revenues 269,016 331,700
Total revenues 20,523,640 13,835,431
Cost of revenues:    
Franchise cost of revenues 2,717,691 2,642,451
IT cost of revenues 221,918 177,462
Total cost of revenues 2,939,609 2,819,913
Selling and marketing expenses 4,419,180 2,843,613
Depreciation and amortization 2,566,136 1,268,955
General and administrative expenses 22,101,083 16,219,392
Total selling, general and administrative expenses 29,086,399 20,331,960
Loss on disposition or impairment 3,520,370
Loss from operations (15,022,738) (9,316,442)
Other (expense) income:    
Bargain purchase gain 261,147
Other income, net 13,295 22,119
Total other (expense) income 13,295 283,266
Loss before income tax expense (15,009,443) (9,033,176)
Income tax (expense) benefit (164,429) 235,855
Net loss and comprehensive loss $ (15,173,872) $ (8,797,321)
Loss per share:    
Basic and diluted loss per share (in dollars per share) $ (1.20) $ (0.88)
Basic and diluted weighted average shares (in shares) 12,696,649 10,042,001